Willamette Clinical Research Inc C/o Salem Hospital- Clinical Trials
Nonprofit profile at a glance
- EIN
- 931158097
- IRS 990-EZ coverage
- 2013–2024
- Forms available
- Form 990-EZ 2024
- Location
- Salem, OR, USA
- Phone
- 5035610002
- Rating confidence
- Limited
- Sector
- Health Treatment Facilities, Primarily Outpatient
Reported finances
- Revenue
- $2,049
- Expenses
- $652
- Assets
- $72,373
- Liabilities
- $652
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
10 people listed
Executive titles in this filing
- MATT GORDON MD (PRESIDENT)
People named in this filing
- NANCY REYES-MOLYNEUX MD (DIRECTOR)
- NATASHA TIFFANY MD (DIRECTOR)
- ROD BOUTIN JD (SECRETARY)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To conduct clinical trials research and provide education in oncology to medical professionals and the public.
What it reported doing in 2024
A % of protocol income is donated to salem hospital, clinical trials budget, since hospital facilities and staff are used in clinical trials.
Operating model
- Revenue model
- Investment-supported. 100% of the money available for current operations came from recurring investment income.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 82
- Sustainability: 84
- Growth: 40
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 68.2%; rating input score 95; 95th percentile among comparable filings
- Total-asset coverage ratio: 111; rating input score 99; 99th percentile among comparable filings
- Liabilities to assets ratio: 0.01; rating input score 29; 29th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: 12.5% per year; rating input score 100; 75th percentile among comparable filings
- Revenue growth: -18.9% per year; rating input score 0; 15th percentile among comparable filings
- Asset growth: -1.7% per year; rating input score 0; 33rd percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 3 filed program accomplishments
- Leadership: top reported pay $0 · 10 people listed
- Consistency: 6 of 6 current checks pass
- Schedules: 2 filed schedules
- Filing history: 11 filing years from 2013 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.
- High — Sustainability: Liabilities to assets ratio scored 29/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.